Cargando…

Physiological effects of intraperitoneal versus subcutaneous insulin infusion in patients with diabetes mellitus type 1: A systematic review and meta-analysis

The intraperitoneal route of administration accounts for less than 1% of insulin treatment regimes in patients with diabetes mellitus type 1 (DM1). Despite being used for decades, a systematic review of various physiological effects of this route of insulin administration is lacking. Thus, the aim o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dirnena-Fusini, Ilze, Åm, Marte Kierulf, Fougner, Anders Lyngvi, Carlsen, Sven Magnus, Christiansen, Sverre Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043377/ https://www.ncbi.nlm.nih.gov/pubmed/33848314 http://dx.doi.org/10.1371/journal.pone.0249611

Ejemplares similares

Intraperitoneal and subcutaneous glucagon delivery in anaesthetized pigs: effects on circulating glucagon and glucose levels
por: Åm, Marte Kierulf, et al.
Publicado: (2020)

Intraperitoneal, subcutaneous and intravenous glucagon delivery and subsequent glucose response in rats: a randomized controlled crossover trial
por: Dirnena-Fusini, Ilze, et al.
Publicado: (2018)

Intraperitoneal insulin administration in pigs: effect on circulating insulin and glucose levels
por: Dirnena-Fusini, Ilze, et al.
Publicado: (2021)

Effect of sensor location on continuous intraperitoneal glucose sensing in an animal model
por: Åm, Marte Kierulf, et al.
Publicado: (2018)

Pharmacokinetics of glucagon after intravenous, intraperitoneal and subcutaneous administration in a pig model
por: Teigen, Ingrid Anna, et al.
Publicado: (2022)

Pharmacokinetics of Intraperitoneally Delivered Glucagon in Pigs: A Hypothesis of First Pass Metabolism
por: Teigen, Ingrid Anna, et al.
Publicado: (2021)

A Review of the Current Challenges Associated with the Development of an Artificial Pancreas by a Double Subcutaneous Approach
por: Christiansen, Sverre Christian, et al.
Publicado: (2017)

Vasodilatory effects of glucagon: A possible new approach to enhanced subcutaneous insulin absorption in artificial pancreas devices
por: Teigen, Ingrid Anna, et al.
Publicado: (2022)

Differences Between Flash Glucose Monitor and Fingerprick Measurements
por: Staal, Odd Martin, et al.
Publicado: (2018)

No impact of gestational diabetes mellitus on pregnancy complications in women with PCOS, regardless of GDM criteria used
por: Fougner, Stine Lyngvi, et al.
Publicado: (2021)

Data driven filtering of bowel sounds using multivariate empirical mode decomposition
por: Kölle, Konstanze, et al.
Publicado: (2019)

Continuous subcutaneous insulin infusion: practical issues
por: Saboo, Banshi D., et al.
Publicado: (2012)

Effects of intraperitoneal insulin versus subcutaneous insulin administration on sex hormone-binding globulin concentrations in patients with type 1 diabetes mellitus
por: Boering, M, et al.
Publicado: (2016)

On the Subcutaneous Injection of Blood, Infusion (Subcutaneous) and Intravenous Transfusion
por: Oehler,, et al.
Publicado: (1888)

A Continuous Subcutaneous Insulin Infusion Needle Break
por: George, Minu M., et al.
Publicado: (2015)

Faster Insulin Aspart for Continuous Subcutaneous Insulin Infusion: Is It Worth It?
por: Rosinha, Patrícia, et al.
Publicado: (2022)

The Lived Experience of Continuous Subcutaneous Insulin Infusion in Adults With Type 1 Diabetes Mellitus: A Phenomenological Inquiry
por: Callahan Fagan, V. Renee, et al.
Publicado: (2021)

Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear
por: Rini, Christopher James, et al.
Publicado: (2015)

Comparison of Mucosal, Subcutaneous and Intraperitoneal Routes of Rat Leptospira Infection
por: Zilber, Anne-Laure, et al.
Publicado: (2016)

Effectiveness of Multiple Daily Injections or Continuous Subcutaneous Insulin Infusion for Children with Type 1 Diabetes Mellitus in Clinical Practice
por: Gong, Chun-xiu, et al.
Publicado: (2014)

Use of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes mellitus: a systematic mapping review
por: Alvarenga, Carolina Spinelli, et al.
Publicado: (2022)

Psychopathology and Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes
por: Rotella, Francesco, et al.
Publicado: (2013)

Does AMH Reflect Follicle Number Similarly in Women with and without PCOS?
por: Christiansen, Sverre C., et al.
Publicado: (2016)

Favourable serum calcification propensity with intraperitoneal as compared with subcutaneous insulin administration in type 1 diabetes
por: van Dijk, Peter R., et al.
Publicado: (2020)

Comparison of the Effects of Continuous Subcutaneous Insulin Infusion and Add-On Therapy with Sitagliptin in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Wan, Heng, et al.
Publicado: (2016)

Short-Term Effect of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection in Perioperative Patients with Type 2 Diabetes Mellitus
por: Song, Wei, et al.
Publicado: (2023)

Subcutaneous ICD implant complicated by an intraperitoneal lead course and device infection
por: Kaufmann, Michael R., et al.
Publicado: (2016)

Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson’s disease
por: Hagell, Peter, et al.
Publicado: (2020)

Evaluation of the Accuracy of Current Tubeless Pumps for Continuous Subcutaneous Insulin Infusion
por: Ziegler, Ralph, et al.
Publicado: (2021)

Prolonged intraperitoneal infusion of 5-fluorouracil using a novel carrier solution.
por: Kerr, D. J., et al.
Publicado: (1996)

Effect of increasing intraperitoneal infusion rates on bupropion hydrochloride-induced seizures in mice
por: Silverstone, Peter H, et al.
Publicado: (2008)

Continuous subcutaneous insulin infusion is associated with a reduced rate of microvascular complications
por: Zabeen, Bedowra, et al.
Publicado: (2015)

Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics
por: Pozzilli, Paolo, et al.
Publicado: (2015)

Continuous subcutaneous insulin infusion and flash glucose monitoring in diabetic hemiballism-hemichorea
por: Qiang, Wei, et al.
Publicado: (2020)

Attenuated RORC Expression in the Presence of EMT Progression in Somatotroph Adenomas following Treatment with Somatostatin Analogs Is Associated with Poor Clinical Recovery
por: Lekva, Tove, et al.
Publicado: (2013)

Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion
por: Aleppo, Grazia, et al.
Publicado: (2021)

Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes: A randomized controlled trial
por: Logtenberg, Susan J., et al.
Publicado: (2009)

Continuous intraperitoneal insulin infusion in type 1 diabetes: a 6-year post-trial follow-up
por: van Dijk, Peter R, et al.
Publicado: (2014)

Effect of intraperitoneal and subcutaneous injection of chondroitin sulphate on the growth of solid Ehrlich ascites tumour.
por: Takeuchi, J.
Publicado: (1967)

Implanted subcutaneous versus intraperitoneal bioscaffold seeded with hepatocyte-like cells: functional evaluation
por: Fares, Amal Elham, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_noe6k0t4um5hdlg82pvd573ecu